Home/Hedge Fund Intelligence/Rigel Pharmaceuticals Inc
Nasdaq: RIGLStockForm 13F30 Jun 2026

Hedge funds that hold Rigel Pharmaceuticals Inc Nasdaq: RIGL

CUSIP 766559702 · who reports it, how much, and how much it matters to them

12 of the 720 hedge fund managers we track reported shares of Rigel Pharmaceuticals Inc (Nasdaq: RIGL) on Form 13F for 30 June 2026. Between them they reported USD 133m. The largest position belongs to Armistice Capital, at USD 65m. The manager with the most riding on it is CM Management, where it is 6.2% of the reported book.

Managers reporting it12of 720 we track
Value they reportUSD 133mshares only, 30 Jun 2026
Funds they run194with a file on PPLI.com
Largest positionUSD 65mArmistice Capital
Typical weight0.0%median share of a manager's book
Heaviest weight6.2%CM Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

12 managers, USD 133m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Rigel Pharmaceuticals Inc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Armistice Capital1 fund on PPLI.comUSD 65m0.8%
2D. E. Shaw & Co.15 funds on PPLI.comUSD 21m0.0%
3Marshall Wace LLP84 funds on PPLI.comUSD 14m0.0%
4CM Management1 fund on PPLI.comUSD 9.8m6.2%
5Two Sigma Investments35 funds on PPLI.comUSD 8.1m0.0%
6Renaissance Technologies13 funds on PPLI.comUSD 5.7m0.0%
7Millennium Management6 funds on PPLI.comUSD 3.7m0.0%
8Squarepoint Ops7 funds on PPLI.comUSD 2.6m0.0%
9Engineers Gate Manager1 fund on PPLI.comUSD 934,0000.0%
10Aquatic Capital Management3 funds on PPLI.comUSD 674,0000.0%
11Graham Capital Management18 funds on PPLI.comUSD 471,0000.0%
12Persistent Asset Partners10 funds on PPLI.comUSD 228,0000.1%
Next: where it matters most
Where it matters most

For CM Management it is 6.2% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1CM ManagementUSD 9.8m6.2%
2Armistice CapitalUSD 65m0.8%
3Persistent Asset PartnersUSD 228,0000.1%
4Aquatic Capital ManagementUSD 674,0000.0%
5Engineers Gate ManagerUSD 934,0000.0%
6Marshall Wace LLPUSD 14m0.0%
7D. E. Shaw & Co.USD 21m0.0%
8Graham Capital ManagementUSD 471,0000.0%
9Renaissance TechnologiesUSD 5.7m0.0%
10Two Sigma InvestmentsUSD 8.1m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Rigel Pharmaceuticals Inc

What is the ticker symbol of Rigel Pharmaceuticals Inc?

Rigel Pharmaceuticals Inc trades under the symbol RIGL on the Nasdaq. Its CUSIP, the code used on Form 13F, is 766559702.

Which hedge funds own Rigel Pharmaceuticals Inc (Nasdaq: RIGL)?

12 of the 720 hedge fund managers PPLI.com tracks reported Rigel Pharmaceuticals Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Armistice Capital (USD 65m), D. E. Shaw & Co. (USD 21m), Marshall Wace LLP (USD 14m), CM Management (USD 9.8m) and Two Sigma Investments (USD 8.1m).

How many hedge funds hold Rigel Pharmaceuticals Inc?

12 managers in our coverage reported it, and between them they run 194 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Rigel Pharmaceuticals Inc?

CM Management, where the position was 6.2% of the reported 13F book at 30 June 2026.

Does this show who is short Rigel Pharmaceuticals Inc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Rigel Pharmaceuticals Inc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.